BNP Paribas Financial Markets’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1
| Closed | -$5 | – | 3542 |
|
|
2020
Q3 | $5 | Hold |
1
| – | – | ﹤0.01% | 3559 |
|
|
2020
Q2 | $3 | Sell |
1
-10
| -91% | -$30 | ﹤0.01% | 3660 |
|
|
2020
Q1 | $27 | Hold |
11
| – | – | ﹤0.01% | 3645 |
|
|
2019
Q4 | $56 | Sell |
11
-66
| -86% | -$336 | ﹤0.01% | 3686 |
|
|
2019
Q3 | $497 | Hold |
77
| – | – | ﹤0.01% | 3773 |
|
|
2019
Q2 | $480 | Sell |
77
-2
| -3% | -$12 | ﹤0.01% | 3779 |
|
|
2019
Q1 | $838 | Sell |
79
-132
| -63% | -$1.4K | ﹤0.01% | 3563 |
|
|
2018
Q4 | $1.68K | Buy |
211
+23
| +12% | +$183 | ﹤0.01% | 3149 |
|
|
2018
Q3 | $3.63K | Hold |
188
| – | – | ﹤0.01% | 3488 |
|
|
2018
Q2 | $3.39K | Sell |
188
-676
| -78% | -$12.2K | ﹤0.01% | 3536 |
|
|
2018
Q1 | $9.19K | Buy |
864
+30
| +4% | +$319 | ﹤0.01% | 3432 |
|
|
2017
Q4 | $35.2K | Buy |
834
+446
| +115% | +$18.8K | ﹤0.01% | 3153 |
|
|
2017
Q3 | $21.3K | Sell |
388
-20
| -5% | -$1.1K | ﹤0.01% | 3046 |
|
|
2017
Q2 | $75.8K | Buy |
408
+388
| +1,940% | +$72K | ﹤0.01% | 2521 |
|
|
2017
Q1 | $2.33K | Sell |
20
-32
| -62% | -$3.73K | ﹤0.01% | 2939 |
|
|
2016
Q4 | $5.18K | Sell |
52
-157
| -75% | -$15.6K | ﹤0.01% | 3107 |
|
|
2016
Q3 | $23.4K | Buy |
209
+89
| +74% | +$9.95K | ﹤0.01% | 2799 |
|
|
2016
Q2 | $12.3K | Buy |
+120
| New | +$12.3K | ﹤0.01% | 2807 |
|
|
2016
Q1 | – | Sell |
-304
| Closed | -$43.9K | – | 3187 |
|
|
2015
Q4 | $43.9K | Sell |
304
-24
| -7% | -$3.47K | ﹤0.01% | 2902 |
|
|
2015
Q3 | $33.9K | Buy |
+328
| New | +$33.9K | ﹤0.01% | 3111 |
|